Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Veruska Lia Fook Alves, Walter Moises Tobias Braga, M.D., Daniela Bertolli Zanatta, Fabricio de Carvalho, Maria de Lourdes Chauffaille, Bryan E. Strauss, Gisele Wally Braga Colleoni, MD

Blood (2013) 122 (21): 3771.

https://doi.org/10.1182/blood.V122.21.3771.3771

Published: 2013

Journal Articles

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Fabricio de Carvalho, Veruska Lia, Fook Alves, Walter Moisés, Tobias Braga, M.D., Celso Vieira Xavier, Jr., Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4974.

https://doi.org/10.1182/blood.V120.21.4974.4974

Published: 2012

Journal Articles

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Walter Moises Tobias Braga, M.D., Bruna Raphaeli Silva, Fabricio de Carvalho, Veruska Lia Fook Alves, Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4985.

https://doi.org/10.1182/blood.V120.21.4985.4985

Published: 2012

Journal Articles

MAGE-C1/CT7 Inhibition Increases Myeloma Cell Line Sensitivity to Bortezomib-Induced Apoptosis: New Target for Myeloma Therapy?

Fabricio de Carvalho, Ph.D., Erico T. Costa, Anamaria A. Camargo, Juliana C. Gregorio, Cibele Masotti, Valeria C.C. Andrade, Bryan E. Strauss, Otavia L. Caballero, Djordje Atanackovic, Gisele W.B. Colleoni

Blood (2010) 116 (21): 1908.

https://doi.org/10.1182/blood.V116.21.1908.1908

Published: 2010

Journal Articles

Stable MAGEC1/CT7 Inhibition by Short Hairpin RNA (shRNA) Does Not Affect Tumor Cell Proliferation and Invasive Potential in Sko-007 Multiple Myeloma Cell Line.

Fabricio de Carvalho, Anamaria A. Camargo, Érico T. Costa, Cibele Masotti, Valéria C.C. Andrade, Bryan E. Strauss, Otávia L. Caballero, Gisele W.B. Colleoni

Blood (2009) 114 (22): 4888.

https://doi.org/10.1182/blood.V114.22.4888.4888

Published: 2009

Journal Articles

Expression of Cancer Testis (CT) Antigens NY-ESO-1 and LAGE-1 in Multiple Myeloma (MM): Could a Vaccine against the Former Antigen Be Effective against the Latter?

Bruno Karia, Fabricio de Carvalho, Valéria C.C. Andrade, Achim A. Jungbluth, André L. Vettore, Gisele W.B. Colleoni

Blood (2009) 114 (22): 4887.

https://doi.org/10.1182/blood.V114.22.4887.4887

Published: 2009

NARROW

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

MAGE-C1/CT7 Inhibition Increases Myeloma Cell Line Sensitivity to Bortezomib-Induced Apoptosis: New Target for Myeloma Therapy?

Stable MAGEC1/CT7 Inhibition by Short Hairpin RNA (shRNA) Does Not Affect Tumor Cell Proliferation and Invasive Potential in Sko-007 Multiple Myeloma Cell Line.

Expression of Cancer Testis (CT) Antigens NY-ESO-1 and LAGE-1 in Multiple Myeloma (MM): Could a Vaccine against the Former Antigen Be Effective against the Latter?

Email alerts

ASH Publications

American Society of Hematology

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

MAGE-C1/CT7 Inhibition Increases Myeloma Cell Line Sensitivity to Bortezomib-Induced Apoptosis: New Target for Myeloma Therapy?

Stable MAGEC1/CT7 Inhibition by Short Hairpin RNA (shRNA) Does Not Affect Tumor Cell Proliferation and Invasive Potential in Sko-007 Multiple Myeloma Cell Line.

Expression of Cancer Testis (CT) Antigens NY-ESO-1 and LAGE-1 in Multiple Myeloma (MM): Could a Vaccine against the Former Antigen Be Effective against the Latter?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only